Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation in Asia (XANAP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01750788
Recruitment Status : Completed
First Posted : December 17, 2012
Last Update Posted : September 21, 2017
Janssen Research & Development, LLC
Information provided by (Responsible Party):

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : October 12, 2015
  Study Completion Date : October 12, 2015